glp-1 side effect class action in louisiana The RA Legal Timeline: How Serious Effects Led to Multidistrict Litigation Full article: Managing the gastrointestinal
Description
Semaglutide 1 mg weekly reduced the composite primary kidney outcome (defined as a 50% or greater eGFR decline, end-stage kidney disease, or kidney or cardiovascular death) by 24% (HR 0.76)
Evidence-based ways to ease it, and when to call your care team
Andreadis P, Karagiannis T, Malandris K, et al
Improved Glycemic Control : Many studies indicate that STDEI GLP-1 medications effectively lower HbA1c levels, contributing to better blood sugar management in individuals with type 2 diabetes
